This report analyzes the emerging global synthetic biology market. It finds that the global synthetic biology market was worth $233.8 million in 2008 and is expected to grow significantly to $2.4 billion by 2013, representing a compound annual growth rate of 59.8%. The chemicals and energy segment currently has the largest market share but the biotechnology and pharmaceuticals segment is the second largest and growing market. The report provides an in-depth analysis of industry trends, technologies, applications, companies and geographic markets within the synthetic biology field.
Prevalence of Intestinal Parasitic Infections among Patients Attended to Alri...CrimsonpublishersCJMI
Prevalence of Intestinal Parasitic Infections among Patients Attended to Alribat University hospital, Khartoum State, Sudan, 2017 by Leonardo Brantes Bacellar Mendes in Cohesive Journal of Microbiology & Infectious Disease
In this study, some typical cases are presented where promotion mechanisms for advanced
biofuels have had an impact on markets and trade, or may be anticipated to impact markets
and trade in the future.
Regulatory framework for genome edited crops in indiaDimple Rajgor
The process or product of genetic engineering technology in India is regulated under
biosafety regulatory framework established under “Manufacture, use, import, export and
storage of hazardous microorganisms/ genetically engineered organisms or cells, Rules 1989
(Rules 1989) under Environment (Protection) Act (EPA), 1986. Living cells and/or organisms
with targeted genetic change(s) in genomes are generally referred as “Genome Edited
cells/organisms”, “Gene Edited cells/organisms” or “Genetically Edited cells/organisms”
(hereinafter referred as GEd organisms).
Regulatory aspects associated with genome editing applications in agriculture...OECD Environment
This presentation addresses the regulatory questions associated with genome editing applications in agriculture in Argentina, with a view to discussing approaches to address them.
Disabled and elderly assistive technologieslinda3395
Assistive technology products are designed to assist people who, because of specific disabilities or the general infirmities that often accompany aging, would otherwise be unable to participate meaningfully in economic, social, political, cultural, and other forms of human activity in their communities
Gastrointestinal Pharmaceuticals: Technologies and MarketsReportLinker.com
Overall sales in the gastrointestinal disorder treatment market amounted to $34.2 billionin 2007, and decreased slightly to $31.1 billion in 2009. By 2014, they are projected to reach $32.2 billion, for a 5-year compound annual growth rate (CAGR) of 0.7%.The largest segment of the market, prescription gastrointestinal drugs, was valued at $27.4 billion in 2008; this is expected to decrease to $26,3 billion in 2009, and to reach $27 billion in 2014, for a 5-year CAGR of 0.5%.
Regenerative Medicines: Bone and Joint ApplicationsReportLinker.com
Provides a comprehensive overview of the global market for regenerative medicines for bone and joint applicationsOffers the background for demographics underlying the market for bone and joint productsContains global market forecasts for regenerative medicines for bone and joint applications, with trends and forecasts for growth through 2014Describes the leading bone and joint diseases and disorders using regenerative technologies, including incidence and current methods of treatmentDiscusses regulatory issues affecting regenerative medicine productsProfiles leading and emerging companies.
Prevalence of Intestinal Parasitic Infections among Patients Attended to Alri...CrimsonpublishersCJMI
Prevalence of Intestinal Parasitic Infections among Patients Attended to Alribat University hospital, Khartoum State, Sudan, 2017 by Leonardo Brantes Bacellar Mendes in Cohesive Journal of Microbiology & Infectious Disease
In this study, some typical cases are presented where promotion mechanisms for advanced
biofuels have had an impact on markets and trade, or may be anticipated to impact markets
and trade in the future.
Regulatory framework for genome edited crops in indiaDimple Rajgor
The process or product of genetic engineering technology in India is regulated under
biosafety regulatory framework established under “Manufacture, use, import, export and
storage of hazardous microorganisms/ genetically engineered organisms or cells, Rules 1989
(Rules 1989) under Environment (Protection) Act (EPA), 1986. Living cells and/or organisms
with targeted genetic change(s) in genomes are generally referred as “Genome Edited
cells/organisms”, “Gene Edited cells/organisms” or “Genetically Edited cells/organisms”
(hereinafter referred as GEd organisms).
Regulatory aspects associated with genome editing applications in agriculture...OECD Environment
This presentation addresses the regulatory questions associated with genome editing applications in agriculture in Argentina, with a view to discussing approaches to address them.
Disabled and elderly assistive technologieslinda3395
Assistive technology products are designed to assist people who, because of specific disabilities or the general infirmities that often accompany aging, would otherwise be unable to participate meaningfully in economic, social, political, cultural, and other forms of human activity in their communities
Gastrointestinal Pharmaceuticals: Technologies and MarketsReportLinker.com
Overall sales in the gastrointestinal disorder treatment market amounted to $34.2 billionin 2007, and decreased slightly to $31.1 billion in 2009. By 2014, they are projected to reach $32.2 billion, for a 5-year compound annual growth rate (CAGR) of 0.7%.The largest segment of the market, prescription gastrointestinal drugs, was valued at $27.4 billion in 2008; this is expected to decrease to $26,3 billion in 2009, and to reach $27 billion in 2014, for a 5-year CAGR of 0.5%.
Regenerative Medicines: Bone and Joint ApplicationsReportLinker.com
Provides a comprehensive overview of the global market for regenerative medicines for bone and joint applicationsOffers the background for demographics underlying the market for bone and joint productsContains global market forecasts for regenerative medicines for bone and joint applications, with trends and forecasts for growth through 2014Describes the leading bone and joint diseases and disorders using regenerative technologies, including incidence and current methods of treatmentDiscusses regulatory issues affecting regenerative medicine productsProfiles leading and emerging companies.
The U.S. medical plastics market is expected to reach almost 3.5 billion pounds by the end of 2010 and will grow at a compound annual growth rate (CAGR) of about 5%, consuming about 4.4 billion pounds by 2015.Commodity thermoplastics dominate the market with a little more than 55% of total volume. This sector is estimated at nearly 2 billion pounds in 2010 and should increase at a compound annual growth rate (CAGR) of 4.8% to reach 2.5 billion pounds in 2015.TPEs, engineering resins, and thermosets will show the most significant growth rates over the next 5 years although they only constitute about 20% of total volume. Of these, TPEs will experience the highest compound annual growth rate (CAGR) of 6.2%, from 68 million pounds in 2010 to 92 million pounds in 2015.
ENGINEERING MICROORGANISMS FOR ENERGY PRODUCTION (JASON, 2006)Ilya Klabukov
ENGINEERING MICROORGANISMS FOR ENERGY PRODUCTION
JASON was asked by the Office of Biological and Environmental Research of the Department of Energy to assess the possibilities for using microorganisms to produce fuels as a metabolic product, in particular hydrogen or ethanol.
We were asked to consider the prospects for achieving such biogenic fuel production in principle and in practice; and what the requirements and fundamental limitations are for achieving viability.
JSR-05-300
June 23, 2006
JASON, The MITRE Corporation
In the ever-evolving landscape of environmental sustainability, the utilization of biological treatment technologies stands as a beacon of hope. According to a comprehensive report by TechSci Research, titled "Global Biological Treatment Technologies Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028," the global market for biological treatment technologies witnessed substantial growth, with a valuation of USD 2.38 billion in 2022. Projections indicate an impressive growth trajectory, with an anticipated Compound Annual Growth Rate (CAGR) of 6.42% through 2028. This growth is attributed to various factors, including collaborations among industry leaders, heightened public and corporate sustainability initiatives, and advancements in technological innovations.
Collaborations and Partnerships: A Catalyst for Growth
One of the driving forces behind the growth of the biological treatment technologies market is the strategic collaborations and partnerships among leading companies. These alliances facilitate the merging of expertise and resources, ultimately strengthening the position of these companies within the market. An illustrative example of such collaborations is the agreement between Lummus Technology and Siemens Energy, announced in May 2023.
Lummus Technology, a global provider of process technologies and energy solutions, seized the opportunity to acquire assets from Siemens Energy's water solutions portfolio. This strategic move encompasses the acquisition of intellectual property, copyrights, trade secrets, and research and development assets. These assets are specifically tailored to address the water and wastewater treatment needs of the oil and gas industry, employing cutting-edge technologies such as carbon adsorption, biological treatment, and hydrothermal processes.
Recent developments in genetic and molecular biology have
excited world-wide interest in biotechnology. The ability to
manipulate DNA has already changed our perceptions of
medicine, agriculture and
environmental
management.
Scientific breakthroughs in gene
expression, protein
engineer-
ing and cell fusion are being
translated by a
strengthening
biotechnology industry into
revolutionary new
products and
services.
In 2012, the global tire market size approximated USD185.8 billion, up 2.6% from a year earlier. The estimation shows that the growth rate in 2013 will be no more than 0.5%.
US demand for roofing is forecast to rise 5.7 percent per year to 263 million squares in 2015, valued at $24.4 billion. This pace represents a turnaround from the 6.1 percent annual declines experienced between 2005 and 2010. Advances will be driven by the rebound in building construction expenditures from their depressed 2010 base.
More Related Content
Similar to Synthetic biology emerging global markets
The U.S. medical plastics market is expected to reach almost 3.5 billion pounds by the end of 2010 and will grow at a compound annual growth rate (CAGR) of about 5%, consuming about 4.4 billion pounds by 2015.Commodity thermoplastics dominate the market with a little more than 55% of total volume. This sector is estimated at nearly 2 billion pounds in 2010 and should increase at a compound annual growth rate (CAGR) of 4.8% to reach 2.5 billion pounds in 2015.TPEs, engineering resins, and thermosets will show the most significant growth rates over the next 5 years although they only constitute about 20% of total volume. Of these, TPEs will experience the highest compound annual growth rate (CAGR) of 6.2%, from 68 million pounds in 2010 to 92 million pounds in 2015.
ENGINEERING MICROORGANISMS FOR ENERGY PRODUCTION (JASON, 2006)Ilya Klabukov
ENGINEERING MICROORGANISMS FOR ENERGY PRODUCTION
JASON was asked by the Office of Biological and Environmental Research of the Department of Energy to assess the possibilities for using microorganisms to produce fuels as a metabolic product, in particular hydrogen or ethanol.
We were asked to consider the prospects for achieving such biogenic fuel production in principle and in practice; and what the requirements and fundamental limitations are for achieving viability.
JSR-05-300
June 23, 2006
JASON, The MITRE Corporation
In the ever-evolving landscape of environmental sustainability, the utilization of biological treatment technologies stands as a beacon of hope. According to a comprehensive report by TechSci Research, titled "Global Biological Treatment Technologies Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028," the global market for biological treatment technologies witnessed substantial growth, with a valuation of USD 2.38 billion in 2022. Projections indicate an impressive growth trajectory, with an anticipated Compound Annual Growth Rate (CAGR) of 6.42% through 2028. This growth is attributed to various factors, including collaborations among industry leaders, heightened public and corporate sustainability initiatives, and advancements in technological innovations.
Collaborations and Partnerships: A Catalyst for Growth
One of the driving forces behind the growth of the biological treatment technologies market is the strategic collaborations and partnerships among leading companies. These alliances facilitate the merging of expertise and resources, ultimately strengthening the position of these companies within the market. An illustrative example of such collaborations is the agreement between Lummus Technology and Siemens Energy, announced in May 2023.
Lummus Technology, a global provider of process technologies and energy solutions, seized the opportunity to acquire assets from Siemens Energy's water solutions portfolio. This strategic move encompasses the acquisition of intellectual property, copyrights, trade secrets, and research and development assets. These assets are specifically tailored to address the water and wastewater treatment needs of the oil and gas industry, employing cutting-edge technologies such as carbon adsorption, biological treatment, and hydrothermal processes.
Recent developments in genetic and molecular biology have
excited world-wide interest in biotechnology. The ability to
manipulate DNA has already changed our perceptions of
medicine, agriculture and
environmental
management.
Scientific breakthroughs in gene
expression, protein
engineer-
ing and cell fusion are being
translated by a
strengthening
biotechnology industry into
revolutionary new
products and
services.
In 2012, the global tire market size approximated USD185.8 billion, up 2.6% from a year earlier. The estimation shows that the growth rate in 2013 will be no more than 0.5%.
US demand for roofing is forecast to rise 5.7 percent per year to 263 million squares in 2015, valued at $24.4 billion. This pace represents a turnaround from the 6.1 percent annual declines experienced between 2005 and 2010. Advances will be driven by the rebound in building construction expenditures from their depressed 2010 base.
This Euromonitor market report provides market trend and market growth analysis of the Home Care industry in Pakistan. With this market report, you’ll be able to explore in detail the changing shape and potential of the industry. You will now be able to plan and build strategy on real industry data and projections.
This Euromonitor market report provides market trend and market growth analysis of the Apparel industry in Germany. With this market report, you’ll be able to explore in detail the changing shape and potential of the industry. You will now be able to plan and build strategy on real industry data and projections.
Product profiles alzheimer's disease immunotherapies can revolutionize trea...linda3395
The beta-amyloid hypothesis has so far failed to deliver a viable candidate, contributing to an absence of new market entrants over the past decade. However, given the weight of candidates with disease-modifying potential in the pipeline, new drugs are expected to emerge that will satisfy one of the biggest unmet needs in the industry – a treatment that slows Alzheimer’s disease neurodegeneration.Market Research Reports, Market Research, Industry Analysis, Market Share, Market Size, marketing research,
Pharmaceutical Market Research,Pharmaceutical Market Research Reports,Pharmaceuticals Market Research,Pharmaceuticals Market Research Reports
As of late September 2011, the relatively few statistics available suggest that non-life premiums contracted in H111, having (probably) shrunk in calendar 2010. Conditions for non-life insurers were far from optimal even before the political unrest in Bahrain earlier this year.
Demand for converted flexible packaging in the US is expected to exceed $18 billion in 2015. Gains will reflect a rebound in the US economy and will be supported by cost, performance and source reduction advantages over most rigid packaging formats.
Demand for biologics will exceed $100 billion in 2015, experiencing continuing strong growth following a decade of double-digit annual increases. Continued growth will be driven by dramatic shifts in production technology and expansion of targeted diseases, and challenged by the introduction of biosimilar products following patent expiry of major biologic products.
The netherlands interior products industry, key trends and opportunitieslinda3395
This report will help you to understand manufacturing, trade, retail and demand-side dynamics within Dutch interior products market highlighting key market trends and growth opportunities
The future of interior products in poland to 2015linda3395
The report provides an indispensable source of market size, distribution and end-user segmentation analysis covering Polish interior products industry.
Nanotechnology a realistic market assessmentlinda3395
This report provide investors and others with information on the commercial potential of various nanotechnologies and to complement the growing body of technical information
Esophageal cancer pipeline review, q3 2011linda3395
This report provides information on the therapeutic development for Esophageal Cancer, complete with latest updates, and special features on late-stage and discontinued projects.
The future of interior products in germany to 2015 demand to gather pace from...linda3395
The report provides an indispensable source of market size, distribution and end-user segmentation analysis covering German interior products industry.
Accelerate your Kubernetes clusters with Varnish CachingThijs Feryn
A presentation about the usage and availability of Varnish on Kubernetes. This talk explores the capabilities of Varnish caching and shows how to use the Varnish Helm chart to deploy it to Kubernetes.
This presentation was delivered at K8SUG Singapore. See https://feryn.eu/presentations/accelerate-your-kubernetes-clusters-with-varnish-caching-k8sug-singapore-28-2024 for more details.
Elevating Tactical DDD Patterns Through Object CalisthenicsDorra BARTAGUIZ
After immersing yourself in the blue book and its red counterpart, attending DDD-focused conferences, and applying tactical patterns, you're left with a crucial question: How do I ensure my design is effective? Tactical patterns within Domain-Driven Design (DDD) serve as guiding principles for creating clear and manageable domain models. However, achieving success with these patterns requires additional guidance. Interestingly, we've observed that a set of constraints initially designed for training purposes remarkably aligns with effective pattern implementation, offering a more ‘mechanical’ approach. Let's explore together how Object Calisthenics can elevate the design of your tactical DDD patterns, offering concrete help for those venturing into DDD for the first time!
Epistemic Interaction - tuning interfaces to provide information for AI supportAlan Dix
Paper presented at SYNERGY workshop at AVI 2024, Genoa, Italy. 3rd June 2024
https://alandix.com/academic/papers/synergy2024-epistemic/
As machine learning integrates deeper into human-computer interactions, the concept of epistemic interaction emerges, aiming to refine these interactions to enhance system adaptability. This approach encourages minor, intentional adjustments in user behaviour to enrich the data available for system learning. This paper introduces epistemic interaction within the context of human-system communication, illustrating how deliberate interaction design can improve system understanding and adaptation. Through concrete examples, we demonstrate the potential of epistemic interaction to significantly advance human-computer interaction by leveraging intuitive human communication strategies to inform system design and functionality, offering a novel pathway for enriching user-system engagements.
Transcript: Selling digital books in 2024: Insights from industry leaders - T...BookNet Canada
The publishing industry has been selling digital audiobooks and ebooks for over a decade and has found its groove. What’s changed? What has stayed the same? Where do we go from here? Join a group of leading sales peers from across the industry for a conversation about the lessons learned since the popularization of digital books, best practices, digital book supply chain management, and more.
Link to video recording: https://bnctechforum.ca/sessions/selling-digital-books-in-2024-insights-from-industry-leaders/
Presented by BookNet Canada on May 28, 2024, with support from the Department of Canadian Heritage.
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...James Anderson
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
Climate Impact of Software Testing at Nordic Testing DaysKari Kakkonen
My slides at Nordic Testing Days 6.6.2024
Climate impact / sustainability of software testing discussed on the talk. ICT and testing must carry their part of global responsibility to help with the climat warming. We can minimize the carbon footprint but we can also have a carbon handprint, a positive impact on the climate. Quality characteristics can be added with sustainability, and then measured continuously. Test environments can be used less, and in smaller scale and on demand. Test techniques can be used in optimizing or minimizing number of tests. Test automation can be used to speed up testing.
Essentials of Automations: The Art of Triggers and Actions in FMESafe Software
In this second installment of our Essentials of Automations webinar series, we’ll explore the landscape of triggers and actions, guiding you through the nuances of authoring and adapting workspaces for seamless automations. Gain an understanding of the full spectrum of triggers and actions available in FME, empowering you to enhance your workspaces for efficient automation.
We’ll kick things off by showcasing the most commonly used event-based triggers, introducing you to various automation workflows like manual triggers, schedules, directory watchers, and more. Plus, see how these elements play out in real scenarios.
Whether you’re tweaking your current setup or building from the ground up, this session will arm you with the tools and insights needed to transform your FME usage into a powerhouse of productivity. Join us to discover effective strategies that simplify complex processes, enhancing your productivity and transforming your data management practices with FME. Let’s turn complexity into clarity and make your workspaces work wonders!
Pushing the limits of ePRTC: 100ns holdover for 100 daysAdtran
At WSTS 2024, Alon Stern explored the topic of parametric holdover and explained how recent research findings can be implemented in real-world PNT networks to achieve 100 nanoseconds of accuracy for up to 100 days.
A tale of scale & speed: How the US Navy is enabling software delivery from l...sonjaschweigert1
Rapid and secure feature delivery is a goal across every application team and every branch of the DoD. The Navy’s DevSecOps platform, Party Barge, has achieved:
- Reduction in onboarding time from 5 weeks to 1 day
- Improved developer experience and productivity through actionable findings and reduction of false positives
- Maintenance of superior security standards and inherent policy enforcement with Authorization to Operate (ATO)
Development teams can ship efficiently and ensure applications are cyber ready for Navy Authorizing Officials (AOs). In this webinar, Sigma Defense and Anchore will give attendees a look behind the scenes and demo secure pipeline automation and security artifacts that speed up application ATO and time to production.
We will cover:
- How to remove silos in DevSecOps
- How to build efficient development pipeline roles and component templates
- How to deliver security artifacts that matter for ATO’s (SBOMs, vulnerability reports, and policy evidence)
- How to streamline operations with automated policy checks on container images
UiPath Test Automation using UiPath Test Suite series, part 4DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 4. In this session, we will cover Test Manager overview along with SAP heatmap.
The UiPath Test Manager overview with SAP heatmap webinar offers a concise yet comprehensive exploration of the role of a Test Manager within SAP environments, coupled with the utilization of heatmaps for effective testing strategies.
Participants will gain insights into the responsibilities, challenges, and best practices associated with test management in SAP projects. Additionally, the webinar delves into the significance of heatmaps as a visual aid for identifying testing priorities, areas of risk, and resource allocation within SAP landscapes. Through this session, attendees can expect to enhance their understanding of test management principles while learning practical approaches to optimize testing processes in SAP environments using heatmap visualization techniques
What will you get from this session?
1. Insights into SAP testing best practices
2. Heatmap utilization for testing
3. Optimization of testing processes
4. Demo
Topics covered:
Execution from the test manager
Orchestrator execution result
Defect reporting
SAP heatmap example with demo
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
SAP Sapphire 2024 - ASUG301 building better apps with SAP Fiori.pdfPeter Spielvogel
Building better applications for business users with SAP Fiori.
• What is SAP Fiori and why it matters to you
• How a better user experience drives measurable business benefits
• How to get started with SAP Fiori today
• How SAP Fiori elements accelerates application development
• How SAP Build Code includes SAP Fiori tools and other generative artificial intelligence capabilities
• How SAP Fiori paves the way for using AI in SAP apps
State of ICS and IoT Cyber Threat Landscape Report 2024 previewPrayukth K V
The IoT and OT threat landscape report has been prepared by the Threat Research Team at Sectrio using data from Sectrio, cyber threat intelligence farming facilities spread across over 85 cities around the world. In addition, Sectrio also runs AI-based advanced threat and payload engagement facilities that serve as sinks to attract and engage sophisticated threat actors, and newer malware including new variants and latent threats that are at an earlier stage of development.
The latest edition of the OT/ICS and IoT security Threat Landscape Report 2024 also covers:
State of global ICS asset and network exposure
Sectoral targets and attacks as well as the cost of ransom
Global APT activity, AI usage, actor and tactic profiles, and implications
Rise in volumes of AI-powered cyberattacks
Major cyber events in 2024
Malware and malicious payload trends
Cyberattack types and targets
Vulnerability exploit attempts on CVEs
Attacks on counties – USA
Expansion of bot farms – how, where, and why
In-depth analysis of the cyber threat landscape across North America, South America, Europe, APAC, and the Middle East
Why are attacks on smart factories rising?
Cyber risk predictions
Axis of attacks – Europe
Systemic attacks in the Middle East
Download the full report from here:
https://sectrio.com/resources/ot-threat-landscape-reports/sectrio-releases-ot-ics-and-iot-security-threat-landscape-report-2024/
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Synthetic biology emerging global markets
1. Synthetic Biology: Emerging Global Markets
Published:September 2011
No.Of Pages:264
Price:US $ 4850
Report Summary
This Report:
* The global market for synthetic biology generated $233.8 million in 2008. This is
expected to increase to $2.4 billion in 2013, for a compound annual growth rate
(CAGR) of 59.8%.
* The chemicals and energy segment has the largest share of the market, worth
$80.6 million in 2008. This should reach $1.6 billion in 2013, for a CAGR of 81.6%.
* The biotechnology and pharmaceuticals segment is the second-largest market
segment, worth 80.3 million in 2008. This segment is projected to increase at a
CAGR of 49.2% to reach $594 million in 2013.
Browse All Biotechnology Market Research Reports
Table of Contents
CHAPTER ONE: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY
INFORMATION SOURCES
RELATED BCC REPORTS
ANALYST CREDENTIALS
BCC ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: SUMMARY
SUMMARY
SUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY,
THROUGH 2013 ($ MILLIONS)
SUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY,
2006-2013 ($ MILLIONS)
SUMMARY (CONTINUED)
2. CHAPTER THREE: OVERVIEW
SYNTHETIC BIOLOGY TECHNOLOGIES COVERED IN THIS REPORT
TABLE 1 SCOPE OF THIS REPORT
WHAT IS SYNTHETIC BIOLOGY?
WHAT IS SYNTHETIC BIOLOGY (CONTINUED)
DEVELOPMENT STAGE OF SYNTHETIC BIOLOGY
FORCES DRIVING SYNTHETIC BIOLOGY MARKET GROWTH
TABLE 2 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
TABLE 2 (CONTINUED)
GLOBAL MARKET POTENTIAL FOR SYNTHETIC BIOLOGY PRODUCTS
TABLE 3 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER,
THROUGH 2013 ($ MILLIONS)
TABLE 4 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY
MARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)
LIFE CYCLE STATUS OF SYNTHETIC BIOLOGY TECHNOLOGIES
TABLE 5 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE
STAGE
THE SYNTHETIC BIOLOGY INDUSTRY
TABLE 6 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
THE SYNTHETIC BIOLOGY INDUSTRY (CONTINUED)
CHAPTER FOUR: SYNTHETIC BIOLOGY TECHNOLOGIES
INTRODUCTION
DEFINITION OF SYNTHETIC BIOLOGY
TABLE 7 SYNTHETIC BIOLOGY DEFINITIONS
HISTORY OF SYNTHETIC BIOLOGY
TABLE 8 SYNTHETIC BIOLOGY HISTORY
PARADIGM SHIFT IN BIOLOGY
TABLE 9 PARADIGM SHIFT OF BIOLOGY
3. TABLE 10 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
FIGURE 1 SCALE OF SYNTHETIC BIOLOGY
SYNTHETIC BIOLOGY TECHNOLOGY OVERVIEW
TABLE 11 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY
ENABLING TECHNOLOGIES
TABLE 12 IMPORTANCE OF ENABLING TECHNOLOGIES
COSTS OF DNA SYNTHESIS AND SEQUENCING
FIGURE 2 DNA SYNTHESIS AND SEQUENCING COSTS, 1990-2008 ($)
FIGURE 3 HUMAN GENOME SEQUENCING COSTS, 1990-2015 ($)
DNA SYNTHESIS TECHNOLOGIES
FIGURE 4 SIMPLIFIED SCHEMATIC OF GENE SYNTHESIS TECHNOLOGY
DNA Synthesis … (Continued)
TABLE 13 COMPARISON OF GENE SYNTHESIS TECHNOLOGIES
PCR-Based Approaches
Solid-Phase Approaches
MICROFLUIDICS TECHNOLOGIES
TABLE 14 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC
BIOLOGY
DNA Microarrays—Oligos Synthesis
TABLE 15 MICROARRAY TYPES
TABLE 16 DNA MICROARRAY PLATFORM FEATURES
TABLE 17 DNA MICROARRAY PLATFORM COMPARISON FOR MAJOR
MANUFACTURERS
TABLE 17 (CONTINUED)
DNA Microarrays—…(Continued)
4. FIGURE 5 MICROARRAYS IN GENE SYNTHESIS
DNA SEQUENCING TECHNOLOGIES
DNA Sequencing TECHNOLOGIES (continued)
FIGURE 6 SEQUENCING THROUGHPUT TREND, 1977-2008
FIGURE 7 DNA SEQUENCING TECHNOLOGIES
BIOINFORMATICS TECHNOLOGIES
TABLE 18 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES
BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS TECHNOLOGIES
TABLE 19 NUCLEIC ACIDS, GENES, AND GENOMES
SYNTHETIC GENES
TABLE 20 SYNTHETIC GENES AS MOLECULAR BIOLOGY TOOL
Synthetic Genes (Continued)
TABLE 21 SYNTHETIC GENES VERSUS PCR CLONING
BIOBRICKS/IGEM PARTS
TABLE 22 BIOBRICKS/IGEM PARTS
FIGURE 8 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGY
SYSTEMS
MINIMAL GENOMES AND CHASSIS ORGANISMS
TABLE 23 ATTRIBUTES OF A MINIMAL GENOME
Minimal Genomes and … (Continued)
CASE STUDY: MINIMAL E.COLI GENOME
Role of Directed Evolution in Designing Biologic Parts
ENABLED TECHNOLOGIES
OVERVIEW
TABLE 24 ENABLED TECHNOLOGIES: EXISTING AND NEAR-TERM
APPLICATIONS
Pathway Engineering
5. FIGURE 9 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTS
TABLE 25 METABOLIC ENGINEERING FOR ARTEMISINIC ACID
Synthetic Microbial Consortia
TABLE 26 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIA
BIOFUELS TECHNOLOGIES
Biofuels Feedstocks
TABLE 27 ENERGY BALANCE OF SELECTED FIRST-GENERATION BIOFUEL
FEEDSTOCKS
Advanced-Generation Biofuels
TABLE 28 FIRST- AND ADVANCED-GENERATION BIOFUELS COMPARED
Cellulosic Biomass
FIGURE 10 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%)
TABLE 29 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTING
CELLULOSIC BIOMASS INTO ETHANOL
Biofuels Types
TABLE 30 EFFICIENCY OF VARIOUS FUELS
Cellulosic Ethanol
FIGURE 11 CELLULOSIC ETHANOL PRODUCTION SCHEMATIC
TABLE 31 CORN ETHANOL COST TARGETS, 2009 ($/GAL. OF ETHANOL)
FIGURE 12 ESTIMATED 25 MGY CELLULOSIC ETHANOL PLANT COSTS (%)
Biodiesel
TABLE 32 IODINE NUMBER OF VARIOUS OILS
Other Biofuels
Role of Genetic Engineering and Synthetic Biology in Biofuels
6. TABLE 33 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELS
CHAPTER FIVE: SYNTHETIC BIOLOGY APPLICATIONS
INTRODUCTION
ENABLING TECHNOLOGIES
TABLE 34 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLING
TECHNOLOGIES
BIOLOGIC COMPONENTS AND INTEGRATED SYSTEMS APPLICATIONS
TABLE 35 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-
TERM APPLICATIONS
SYNTHETIC GENE APPLICATIONS
TABLE 36 SYNTHETIC GENES NEAR-TERM APPLICATIONS
Synthetic Gene Applications (Continued)
Synthetic Gene Applications (Continued)
BIOBRICKS/IGEM PARTS APPLICATIONS
INTEGRATED SYSTEMS APPLICATIONS
Synthetic Cells and Tissues
ENABLED PRODUCTS APPLICATIONS
TABLE 37 ENABLED PRODUCTS NEAR-TERM APPLICATIONS
APPLICATIONS BY END-USER INDUSTRY
RESEARCH AND DEVELOPMENT APPLICATIONS
TABLE 38 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETIC
BIOLOGY PRODUCTS
PHARMACEUTICALS APPLICATIONS
TABLE 39 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FOR
SYNTHETIC BIOLOGY PRODUCTS
Pharmaceuticals Applications (Continued)
TABLE 40 PIPELINE OF SYNTHETIC BIOLOGY-ENABLED DRUGS
ENERGY APPLICATIONS
TABLE 41 ETHANOL AND BIODIESEL FEEDSTOCKS AND PRODUCTION
PROCESSES
7. TABLE 42 ETHANOL AND BIODIESEL COMMON BLENDS
TABLE 43 FIRST-GENERATION FUEL ETHANOL GLOBAL PRODUCTION AND
GOALS, 2007 (MILLION GALS.)
TABLE 44 FIRST-GENERATION BIODIESEL PRODUCTION AND GOALS, 2007
(MILLION GALS.)
United States
FIGURE 13 RENEWABLE FUELS STANDARDS, UNITED STATES, 2008-2013
(BILLION GALS./ YR)
TABLE 45 DOE FUNDING FOR CELLULOSIC BIOFUELS, 2007-2011 ($
MILLIONS)
Canada
Brazil
CHEMICAL INDUSTRY APPLICATIONS
Chemical Industry Applications (Continued)
CHAPTER SIX: SYNTHETIC BIOLOGY INDUSTRY
INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN
FIGURE 14 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETIC
BIOLOGY LEVERAGE POINTS
INDUSTRY STRUCTURAL FORCES
TABLE 46 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCES
INDUSTRY STRUCTURAL FORCES (CONTINUED)
PRODUCTS AND TECHNOLOGY LIFE CYCLE
TABLE 47 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE
STAGE
INDUSTRY COMPETITOR POSITIONING
TABLE 48 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
GENE SYNTHESIS INDUSTRY
GENE SYNTHESIS WORKFLOW
TABLE 49 GENE SYNTHESIS WORKFLOW
Gene Synthesis Workflow (Continued)
8. GENE SYNTHESIS COMPETITOR STRATEGIES
FIGURE 15 SYNTHETIC GENE COMPANY ESTIMATED MARKET SHARES, 2008
(%)
Gene Synthesis … (Continued)
TABLE 50 SYNTHETIC GENE KEY COMPETITOR STRATEGIES
Gene Synthesis … (Continued)
Gene Synthesis Value Chain
Synthetic Gene Market Segments
Automated, Standardized Market Segment
Value-Added Market Segments
TABLE 51 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATION
BIOFUELS INDUSTRY
COMPETITIVE DIFFERENTIATION
FEEDSTOCKS
TABLE 52 BIOFUELS: FEEDSTOCKS, PRODUCTION, AND PRODUCTS
FIGURE 16 BIOFUELS FEEDSTOCKS: RELATIVE COSTS AND VOLUMES
Sugars/Starches
Vegetable Oils
Biomass
Algae
TABLE 53 BIODIESEL YIELD OF SELECTED CROPS (GALS./ACRE/YR.)
CO2
CELLULOSIC ETHANOL INDUSTRY
TABLE 54 CELLULOSIC ETHANOL PLANTS (MGY)
Cellulosic Ethanol Industry (Continued)
BIOFUELS COMPETITOR STRATEGIES
TABLE 55 SYNTHETIC BIOLOGY-BASED BIOFUELS COMPANY STRATEGIES
TABLE 55 (CONTINUED)
Agrivida
Amyris
BP 116
9. DuPont
Gevo
LS9
Mascoma
OpX Biotechnologies
Sequesco
Solazyme
Synthetic Genomics
Verdezyne
Verenium
ROLE OF BIOFUELS FOUNDERS AND INVESTORS
TABLE 56 ROLE OF INVESTORS AND FOUNDERS IN BIOFUELS COMPANIES
ENZYMES INDUSTRY
TABLE 57 ENZYME COMPANY KEY ALLIANCES
PHARMACEUTICALS INDUSTRY
TABLE 58 PHARMACEUTICALS COMPANY STRATEGIES
INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES
TABLE 59 INDUSTRY ACQUISITIONS, 2006-2008
TABLE 60 SYNTHETIC BIOLOGY STRATEGIC ALLIANCES, 2006-2009
TABLE 60 (CONTINUED)
TABLE 60 (CONTINUED)
BIODEFENSE ISSUES
TABLE 61 FUTURE SYNTHETIC BIOLOGY SECURITY REGULATIONS
SUPPORTING INDUSTRY ORGANIZATIONS
TABLE 62 SYNTHETIC BIOLOGY ENABLING ORGANIZATIONS
TABLE 62 (CONTINUED)
SUPPORTING INDUSTRY … (CONTINUED)
FIGURE 17 GROWTH IN IGEM (NUMBER)
CHAPTER SEVEN: SYNTHETIC BIOLOGY MARKETS
10. GROWTH DRIVING FORCES
TABLE 63 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
FIGURE 18 NIH BUDGET OUTLAYS, 2000-2009 ($ BILLIONS)
FIGURE 19 SYNTHETIC BIOLOGY RESEARCH PUBLICATIONS, 2000-2008
(NUMBER)
MARKET FORECASTS
FIGURE 20 MARKET FORECAST SCENARIO TABLE
SYNTHETIC BIOLOGY MARKETS BY INDUSTRY
Summary
TABLE 64 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER,
THROUGH 2013 ($ MILLIONS)
R&D Market
TABLE 65 GLOBAL VALUE OF R&D MARKET BY APPLICATION, THROUGH
2013 ($ MILLIONS)
Biotechnology and Pharmaceuticals Market
TABLE 66 GLOBAL VALUE OF BIOTECHNOLOGY AND PHARMACEUTICALS
MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
Chemicals Market
TABLE 67 GLOBAL VALUE OF CHEMICALS MARKET BY PRODUCT TYPE,
THROUGH 2013 ($ MILLIONS)
Energy Market
TABLE 68 GLOBAL VALUE OF ENERGY MARKET BY PRODUCT TYPE,
THROUGH 2013 ($ MILLIONS)
FIGURE 21 S-CURVE FOR SECOND-GENERATION BIOFUELS
TABLE 69 WORLD BIODIESEL PRODUCTION AND CAPACITY TRENDS, 2002-
2008 (MILLIONS TONS/YR)
TABLE 70 GLOBAL BIOFUELS SUPPLY BY PRODUCT CLASS, THROUGH 2013
(KBOED)
11. FIGURE 22 GLOBAL BIOFUELS MARKET, 2013 (GALS./YR.)
FIGURE 22 (CONTINUED)
FIGURE 23 GLOBAL CELLULOSIC SECOND-GENERATION BIOFUELS MARKET,
2013 (GALS./YR)
FIGURE 23 (CONTINUED)
FIGURE 24 UNITED STATES BIOFUELS MARKET GOALS, 2022 (%)
SYNTHETIC BIOLOGY MARKETS BY PRODUCT TYPE
Summary
TABLE 71 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT
TYPE, THROUGH 2013 ($ MILLIONS)
Summary (Continued)
Enabling Products Market
TABLE 72 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLING PRODUCTS
MARKET, THROUGH 2013 ($ MILLIONS)
Biological Parts Market
TABLE 73 GLOBAL VALUE OF DNA SYNTHESIS MARKET BY TYPE, THROUGH
2013 ($ MILLIONS)
TABLE 74 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY TYPE, THROUGH
2013 ($ MILLIONS)
Standardized Market Segment
Value-Added Market Segments
TABLE 75 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY END USER
INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 76 GLOBAL VALUE OF BIOLOGIC PARTS BY SUPPLIER TYPE,
THROUGH 2013 ($ MILLIONS)
TABLE 77 HOMEBREW VERSUS COMMERCIAL COST COMPARISON FOR
SYNTHESIZING A TYPICAL 714 BP GFP GENE ($)
Integrated Systems Market
TABLE 78 GLOBAL VALUE OF SYNTHETIC BIOLOGY INTEGRATED SYSTEMS
12. MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
Enabled Products Market
TABLE 79 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED PRODUCTS
MARKET BY INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 80 GLOBAL VALUE OF ENABLED R&D MARKET BY PRODUCT TYPE,
THROUGH 2013 ($ MILLIONS)
TABLE 81 GLOBAL VALUE OF ENABLED PHARMACEUTICALS MARKET BY
PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 82 GLOBAL VALUE OF ENABLED CHEMICALS MARKET BY PRODUCT
TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 82 (CONTINUED)
TABLE 83 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY
MARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)
SYNTHETIC BIOLOGY MARKET BY GEOGRAPHIC REGION
Summary
TABLE 84 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY
GEOGRAPHIC REGION, THROUGH 2013 ($ MILLIONS)
Importance of Geography to Fuels Markets
Importance of Geography … (Continued)
CHAPTER EIGHT: PATENT STATUS
INTRODUCTION
FOUNDATIONAL PATENTS
TABLE 85 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTS
SYNTHETIC BIOLOGY INDUSTRY PATENT ANALYSIS
SYNTHETIC BIOLOGY INDUSTRY (continued)
FIGURE 25 NUMBER OF PATENTS BY COMPANY
FIGURE 25 (CONTINUED)
TABLE 86 PATENT DESCRIPTION BY COMPANY
13. FIGURE 26 SYNTHETIC BIOLOGY PATENTS BY COMPANY AND SUBCLASS
(NUMBER OF PATENTS)
FIGURE 26 (CONTINUED)
LITIGATION STATUS
TABLE 87 IP LITIGATION STATUS
IP STRATEGY OF SELECTED SYNTHETIC BIOLOGY COMPANIES
METABOLIX
DUPONT
GENEART
FEBIT
CHAPTER NINE: COMPANY PROFILES
AGRIVIDA
AMYRIS BIOTECHNOLOGIES, INC.
TABLE 88 AMYRIS BIODIESEL ADVANTAGES
ATG BIOSYNTHETICS GMBH
BASF AG
BIO BASIC, INC.
BIOCAT GMBH
BIONEER CORP.
BIONEXUS, INC.
BIO S&T, INC.
BIOTICA TECHNOLOGY, LTD.
BIOTICA TECHNOLOGY, LTD. (CONTINUED)
TABLE 89 STRUCTURE-FUNCTION APPROACH FOR RAPAMYCIN
TABLE 90 BIOTICA PROJECTS PIPELINE
BLUE HERON BIOTECHNOLOGIES
BRISTOL-MYERS SQUIBB
BRISTOL-MYERS SQUIBB (CONTINUED)
BRITISH PETROLEUM
CELLICON BIOTECHNOLOGIES, INC.
CODEXIS, INC
CODON DEVICES, INC.
DANISCO A/S
DNA 2.0
TABLE 91 DNA2.0 STRATEGIC ALLIANCES
14. DRATHS CORP
DUPONT
DUPONT (CONTINUED)
DYADIC INTERNATIONAL, INC.
ENTELECHON GMBH
EPOCH BIOLABS, INC.
ERAGEN BIOSCIENCES, INC.
EUROFINS MEDIGENOMIX GMBH
EUROFINS MWG OPERON
FEBIT SYNBIO GMBH
GENEART AG
TABLE 92 GENEART MAJOR STRATEGIC ALLIANCES
GENEART AG (CONTINUED)
GENEMED SYNTHESIS, INC.
GENSCRIPT CORP.
GENEWORKS PTY, LTD.
GEVO, INC.
TABLE 93 GEVO ISOBUTANOL PRODUCTION FORECAST (GALS./YR.)
HELICOS BIOSCIENCES CORP.
HELICOS BIOSCIENCES CORP. (CONTINUED)
HELICOS BIOSCIENCES CORP. (CONTINUED)
INTEGRATED DNA TECHNOLOGIES
ILLUMINA, INC.
ILLUMINA, INC. (CONTINUED)
INSTITUTE FOR ONEWORLD HEALTH
IOGEN CORP.
JOULE BIOTECHNOLOGIES, INC.
KHOSLA VENTURES
TABLE 94 KHOSLA VENTURES BIOFUELS INVESTMENT PORTFOLIO
LC SCIENCES
LIFE TECHNOLOGIES
LIFE TECHNOLOGIES (CONTINUED)
LS9, INC.
MASCOMA
TABLE 95 MASCOMA INTELLECTUAL PROPERTY STATUS
MAXYGEN
MERCK & CO.
METABOLIX, INC.
15. TABLE 96 METABOLOMIX BUSINESS STRATEGY
METRIGEN, INC.
NOVOZYMES A/S
OMEGA BIO-TEK, INC.
OPX BIOTECHNOLOGIES, INC.
PACIFIC BIOSCIENCES
PFIZER
PROTOLIFE SRL
QTEROS
ROCHE LIFE SCIENCES
ROCHE LIFE SCIENCES (CONTINUED)
ROYAL DSM N.V.
SANGAMO BIOSCIENCES, INC.
SANGAMO BIOSCIENCES, INC. (CONTINUED)
SANOFI AVENTIS
SCARAB GENOMICS, LLC
SEQUESCO
SLONING BIOTECHNOLOGY, GMBH
SOLAZYME, INC.
TABLE 97 SOLAZYME STRATEGIC ALLIANCES
SYNTHETIC GENOMICS
SYNTHETIC GENOMICS (CONTINUED)
TABLE 98 SYNTHETIC GENOMICS STRATEGIC ALLIANCES
VERDEZYNE
TABLE 99 VERDEZYNE STRATEGIC COLLABORATIONS
VERENIUM CORP.
VERENIUM CORP. (CONTINUED)
LIST OF TABLES
SUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY,
THROUGH 2013 ($ MILLIONS)
TABLE 1 SCOPE OF THIS REPORT
TABLE 2 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
TABLE 3 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER,
THROUGH 2013 ($ MILLIONS)
TABLE 4 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY
FUEL TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 5 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
TABLE 6 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
16. TABLE 7 SYNTHETIC BIOLOGY DEFINITIONS
TABLE 8 SYNTHETIC BIOLOGY HISTORY
TABLE 9 PARADIGM SHIFT OF BIOLOGY
TABLE 10 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
TABLE 11 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY
TABLE 12 IMPORTANCE OF ENABLING TECHNOLOGIES
TABLE 13 COMPARISON OF GENE SYNTHESIS TECHNOLOGIES
TABLE 14 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC
BIOLOGY
TABLE 15 MICROARRAY TYPES
TABLE 16 DNA MICROARRAY PLATFORM FEATURES
TABLE 17 DNA MICROARRAY PLATFORM COMPARISON FOR MAJOR
MANUFACTURERS
TABLE 18 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES
TABLE 19 NUCLEIC ACIDS, GENES, AND GENOMES
TABLE 20 SYNTHETIC GENES AS MOLECULAR BIOLOGY TOOL
TABLE 21 SYNTHETIC GENES VERSUS PCR CLONING
TABLE 22 BIOBRICKS/IGEM PARTS
TABLE 23 ATTRIBUTES OF A MINIMAL GENOME
TABLE 24 ENABLED TECHNOLOGIES: EXISTING AND NEAR-TERM APPLICATIONS
TABLE 25 METABOLIC ENGINEERING FOR ARTEMISINIC ACID
TABLE 26 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIA
TABLE 27 ENERGY BALANCE OF SELECTED FIRST-GENERATION BIOFUEL
FEEDSTOCKS
TABLE 28 FIRST- AND ADVANCED-GENERATION BIOFUELS COMPARED
TABLE 29 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTING CELLULOSIC
BIOMASS INTO ETHANOL
TABLE 30 EFFICIENCY OF VARIOUS FUELS
TABLE 31 CORN ETHANOL COST TARGETS, 2009 ($/GAL. OF ETHANOL)
TABLE 32 IODINE NUMBER OF VARIOUS OILS
TABLE 33 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELS
TABLE 34 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLING
TECHNOLOGIES
TABLE 35 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERM
APPLICATIONS
TABLE 36 SYNTHETIC GENES NEAR-TERM APPLICATIONS
TABLE 37 ENABLED PRODUCTS NEAR-TERM APPLICATIONS
TABLE 38 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY
PRODUCTS
TABLE 39 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FOR SYNTHETIC
BIOLOGY PRODUCTS
TABLE 40 PIPELINE OF SYNTHETIC BIOLOGY-ENABLED DRUGS
TABLE 41 ETHANOL AND BIODIESEL FEEDSTOCKS AND PRODUCTION PROCESSES
TABLE 42 ETHANOL AND BIODIESEL COMMON BLENDS
TABLE 43 FIRST-GENERATION FUEL ETHANOL GLOBAL PRODUCTION AND GOALS,
2007 (MILLION GALS.)
TABLE 44 FIRST-GENERATION BIODIESEL PRODUCTION AND GOALS, 2007
17. (MILLION GALS.)
TABLE 45 DOE FUNDING FOR CELLULOSIC BIOFUELS, 2007-2011 ($ MILLIONS)
TABLE 46 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCES
TABLE 47 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
TABLE 48 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
TABLE 49 GENE SYNTHESIS WORKFLOW
TABLE 50 SYNTHETIC GENE KEY COMPETITOR STRATEGIES
TABLE 51 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATION
TABLE 52 BIOFUELS: FEEDSTOCKS, PRODUCTION, AND PRODUCTS
TABLE 53 BIODIESEL YIELD OF SELECTED CROPS (GALS./ACRE/YR.)
TABLE 54 CELLULOSIC ETHANOL PLANTS (MGY)
TABLE 55 SYNTHETIC BIOLOGY-BASED BIOFUELS COMPANY STRATEGIES
TABLE 56 ROLE OF INVESTORS AND FOUNDERS IN BIOFUELS COMPANIES
TABLE 57 ENZYME COMPANY KEY ALLIANCES
TABLE 58 PHARMACEUTICALS COMPANY STRATEGIES
TABLE 59 INDUSTRY ACQUISITIONS, 2006-2008
TABLE 60 SYNTHETIC BIOLOGY STRATEGIC ALLIANCES, 2006-2009
TABLE 61 FUTURE SYNTHETIC BIOLOGY SECURITY REGULATIONS
TABLE 62 SYNTHETIC BIOLOGY ENABLING ORGANIZATIONS
TABLE 63 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
TABLE 64 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER,
THROUGH 2013 ($ MILLIONS)
TABLE 65 GLOBAL VALUE OF R&D MARKET BY APPLICATION, THROUGH 2013 ($
MILLIONS)
TABLE 66 GLOBAL VALUE OF BIOTECHNOLOGY AND PHARMACEUTICALS MARKET
BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 67 GLOBAL VALUE OF CHEMICALS MARKET BY PRODUCT TYPE, THROUGH
2013 ($ MILLIONS)
TABLE 68 GLOBAL VALUE OF ENERGY MARKET BY PRODUCT TYPE, THROUGH 2013
($ MILLIONS)
TABLE 69 WORLD BIODIESEL PRODUCTION AND CAPACITY TRENDS, 2002-2008
(MILLIONS TONS/YR)
TABLE 70 GLOBAL BIOFUELS SUPPLY BY PRODUCT CLASS, THROUGH 2013
(KBOED)
TABLE 71 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT TYPE,
THROUGH 2013 ($ MILLIONS)
TABLE 72 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLING PRODUCTS MARKET,
THROUGH 2013 ($ MILLIONS)
TABLE 73 GLOBAL VALUE OF DNA SYNTHESIS MARKET BY TYPE, THROUGH 2013 ($
MILLIONS)
TABLE 74 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY TYPE, THROUGH 2013
($ MILLIONS)
TABLE 75 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY END USER INDUSTRY,
THROUGH 2013 ($ MILLIONS)
TABLE 76 GLOBAL VALUE OF BIOLOGIC PARTS BY SUPPLIER TYPE, THROUGH 2013
($ MILLIONS)
TABLE 77 HOMEBREW VERSUS COMMERCIAL COST COMPARISON FOR
18. SYNTHESIZING A TYPICAL 714 BP GFP GENE ($)
TABLE 78 GLOBAL VALUE OF SYNTHETIC BIOLOGY INTEGRATED SYSTEMS MARKET
BY TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 79 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED PRODUCTS MARKET
BY INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 80 GLOBAL VALUE OF ENABLED R&D MARKET BY PRODUCT TYPE, THROUGH
2013 ($ MILLIONS)
TABLE 81 GLOBAL VALUE OF ENABLED PHARMACEUTICALS MARKET BY PRODUCT
TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 82 GLOBAL VALUE OF ENABLED CHEMICALS MARKET BY PRODUCT TYPE,
THROUGH 2013 ($ MILLIONS)
TABLE 83 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY
FUEL TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 84 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY GEOGRAPHIC
REGION, THROUGH 2013 ($ MILLIONS)
TABLE 85 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTS
TABLE 86 PATENT DESCRIPTION BY COMPANY
TABLE 87 IP LITIGATION STATUS
TABLE 88 AMYRIS BIODIESEL ADVANTAGES
TABLE 89 STRUCTURE-FUNCTION APPROACH FOR RAPAMYCIN
TABLE 90 BIOTICA PROJECTS PIPELINE
TABLE 91 DNA2.0 STRATEGIC ALLIANCES
TABLE 92 GENEART MAJOR STRATEGIC ALLIANCES
TABLE 93 GEVO ISOBUTANOL PRODUCTION FORECAST (GALS./YR.)
TABLE 94 KHOSLA VENTURES BIOFUELS INVESTMENT PORTFOLIO
TABLE 95 MASCOMA INTELLECTUAL PROPERTY STATUS
TABLE 96 METABOLOMIX BUSINESS STRATEGY
TABLE 97 SOLAZYME STRATEGIC ALLIANCES
TABLE 98 SYNTHETIC GENOMICS STRATEGIC ALLIANCES
TABLE 99 VERDEZYNE STRATEGIC COLLABORATIONS
LIST OF FIGURES
SUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY,
2006-2013 ($ MILLIONS)
FIGURE 1 SCALE OF SYNTHETIC BIOLOGY
FIGURE 2 DNA SYNTHESIS AND SEQUENCING COSTS, 1990-2008 ($)
FIGURE 3 HUMAN GENOME SEQUENCING COSTS, 1990-2015 ($)
FIGURE 4 SIMPLIFIED SCHEMATIC OF GENE SYNTHESIS TECHNOLOGY
FIGURE 5 MICROARRAYS IN GENE SYNTHESIS
FIGURE 6 SEQUENCING THROUGHPUT TREND, 1977-2008
FIGURE 7 DNA SEQUENCING TECHNOLOGIES
FIGURE 8 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGY
SYSTEMS
FIGURE 9 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTS
FIGURE 10 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%)
FIGURE 11 CELLULOSIC ETHANOL PRODUCTION SCHEMATIC
19. FIGURE 12 ESTIMATED 25 MGY CELLULOSIC ETHANOL PLANT COSTS (%)
FIGURE 13 RENEWABLE FUELS STANDARDS, UNITED STATES, 2008-2013 (BILLION
GALS./ YR)
FIGURE 14 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETIC
BIOLOGY LEVERAGE POINTS
FIGURE 15 SYNTHETIC GENE COMPANY ESTIMATED MARKET SHARES, 2008 (%)
FIGURE 16 BIOFUELS FEEDSTOCKS: RELATIVE COSTS AND VOLUMES
FIGURE 17 GROWTH IN IGEM
FIGURE 18 NIH BUDGET OUTLAYS, 2000-2009 ($ BILLIONS)
FIGURE 19 SYNTHETIC BIOLOGY RESEARCH PUBLICATIONS, 2000-2008 (NUMBER)
FIGURE 20 MARKET FORECAST SCENARIO TABLE
FIGURE 21 S-CURVE FOR SECOND-GENERATION BIOFUELS
FIGURE 22 GLOBAL BIOFUELS MARKET, 2013 (GALS./YR.)
FIGURE 23 2013 GLOBAL CELLULOSIC SECOND-GENERATION BIOFUELS MARKET
(GALS./YR)
FIGURE 24 UNITED STATES BIOFUELS MARKET GOALS, 2022 (%)
FIGURE 25 NUMBER OF PATENTS BY COMPANY
FIGURE 26 SYNTHETIC BIOLOGY PATENTS BY COMPANY AND SUBCLASS (NUMBER
OF PATENTS)
About Us:
ReportsnReports is an online library of over 100,000+ market research reports and
in-depth market research studies & analysis of over 5000 micro markets. We
provide 24/7 online and offline support to our customers. Get in touch with us for
your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page:
http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit our Market Research Blog